BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3024787)

  • 1. L-649,923, sodium (beta S*, gamma R*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)- gamma-hydroxy-beta-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist.
    Jones TR; Young R; Champion E; Charette L; Denis D; Ford-Hutchinson AW; Frenette R; Gauthier JY; Guindon Y; Kakushima M
    Can J Physiol Pharmacol; 1986 Aug; 64(8):1068-75. PubMed ID: 3024787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-648,051, sodium 4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)- propylsulfonyl]-gamma-oxo-benzenebutanoate: a leukotriene D4 receptor antagonist.
    Jones TR; Guindon Y; Young R; Champion E; Charette L; Denis D; Ethier D; Hamel R; Ford-Hutchinson AW; Fortin R
    Can J Physiol Pharmacol; 1986 Dec; 64(12):1535-42. PubMed ID: 3030524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist.
    Jones TR; Zamboni R; Belley M; Champion E; Charette L; Ford-Hutchinson AW; Frenette R; Gauthier JY; Leger S; Masson P
    Can J Physiol Pharmacol; 1989 Jan; 67(1):17-28. PubMed ID: 2540892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-649,923, sodium (beta S*, gamma R*-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propylthio)-gamma-hydroxy -beta-methylbenzenebutanoate. A selective, orally active leukotriene D4 receptor antagonist.
    Young RN; Guindon Y; Jones TR; Ford-Hutchinson AW; Bélanger P; Champion E; Charette L; DeHaven RN; Denis D; Fortin R
    Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():37-45. PubMed ID: 3028100
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.
    Jones TR; Labelle M; Belley M; Champion E; Charette L; Evans J; Ford-Hutchinson AW; Gauthier JY; Lord A; Masson P
    Can J Physiol Pharmacol; 1995 Feb; 73(2):191-201. PubMed ID: 7621356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum.
    Bäck M; Jonsson EW; Dahlén SE
    Eur J Pharmacol; 1996 Dec; 317(1):107-13. PubMed ID: 8982726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of sodium (beta R*, gamma S*)-4-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl] thio]-gamma-hydroxy-beta-methylbenzenebutanoate: a novel, selective, and orally active receptor antagonist of leukotriene D4.
    Young RN; Bélanger P; Champion E; DeHaven RN; Denis D; Ford-Hutchinson AW; Fortin R; Frenette R; Gauthier JY; Gillard J
    J Med Chem; 1986 Sep; 29(9):1573-6. PubMed ID: 3746809
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on L-640,035: a novel antagonist of contractile prostanoids in the lung.
    Carrier R; Cragoe EJ; Ethier D; Ford-Hutchinson AW; Girard Y; Hall RA; Hamel P; Rokach J; Share NN; Stone CA
    Br J Pharmacol; 1984 Jun; 82(2):389-95. PubMed ID: 6428502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.
    Tomioka K; Yamada T; Mase T; Hara H; Murase K
    Arzneimittelforschung; 1988 May; 38(5):682-5. PubMed ID: 3415708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571.
    Jones TR; Zamboni R; Belley M; Champion E; Charette L; Ford-Hutchinson AW; Gauthier JY; Leger S; Lord A; Masson P
    Can J Physiol Pharmacol; 1991 Dec; 69(12):1847-54. PubMed ID: 1666333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic action of DS-4574 against leukotrienes in guinea-pig smooth muscle.
    Aibara S; Mori M; Iwamoto T; Chiba T; Tsukada W
    Arch Int Pharmacodyn Ther; 1991; 314():147-59. PubMed ID: 1668601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.
    Hay DW; Muccitelli RM; Tucker SS; Vickery-Clark LM; Wilson KA; Gleason JG; Hall RF; Wasserman MA; Torphy TJ
    J Pharmacol Exp Ther; 1987 Nov; 243(2):474-81. PubMed ID: 2824747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological evaluation of LY 170680, a novel leukotriene D4 and E4 antagonist in the guinea-pig.
    Boot JR; Bond A; Gooderham R; O'Brien A; Parsons M; Thomas KH
    Br J Pharmacol; 1989 Sep; 98(1):259-67. PubMed ID: 2553189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel leukotriene D4/E4 antagonist, SR2640 (2-[3-(2-quinolylmethoxy)phenylamino]benzoic acid).
    Ahnfelt-Rønne I; Kirstein D; Kaergaard-Nielsen C
    Eur J Pharmacol; 1988 Oct; 155(1-2):117-28. PubMed ID: 2854067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes.
    Tudhope SR; Cuthbert NJ; Abram TS; Jennings MA; Maxey RJ; Thompson AM; Norman P; Gardiner PJ
    Eur J Pharmacol; 1994 Nov; 264(3):317-23. PubMed ID: 7698171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-([4- (1H-tetrazol-5-ylmethyl)phenoxy]methyl) phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4.
    Fleisch JH; Rinkema LE; Haisch KD; McCullough D; Carr FP; Dillard RD
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):70-7. PubMed ID: 3016562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
    Yamada N; Yamada K; Takahashi K; Nakao E; Kadowaki S; Umezu K
    Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
    Ishimura M; Kataoka S; Suda M; Maeda T; Hiyama Y
    Allergol Int; 2006 Dec; 55(4):403-10. PubMed ID: 17130683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide leukotriene antagonistic activity of AS-35, a new antiallergic drug.
    Kasai H; Kawashima T; Omura S; Yanagihara Y
    Jpn J Pharmacol; 1992 Apr; 58(4):347-55. PubMed ID: 1405032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.